neo-t
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 28, 2022 (NCT05798546)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06224049 | Early Phase 1 (Phase 1) | Dec 1, 2023 | BGI Group, Shenzhen University |
| NCT05798533 | Phase 1 | Jan 10, 2023 | BGI Group, Fudan University, Huazhong University of Science and Technology |
| NCT05798546 | Phase 1 | Sep 28, 2022 | BGI Group, Huazhong University of Science and Technology |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BGI Group | For profit | 3 | 3 | 1 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 0 | 1 | 2022 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Shenzhen University | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1